Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, et al
Hi, Might be worth posting your update in a new thread as responses on older threads sometimes get missed
The full primary sequence, as published in the Sikiric laboratory's foundational work and reproduced across subsequent literature, is: Sequence (one-letter): GEPPPGKPADDAGLV Sequence (three-letter): Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Length: 15 amino acids (pentadecapeptide) Molecular weight: 1419.5 Da (monoisotopic) Molecular formula: C 62 H 98 N 16 O 22 Designation: "BPC" = Body Protection Compound
It's a single-use option, so it isn't meant for vials you'll draw from repeatedly.
For nasal delivery specifically, TB-500 molecular size presents considerations
Det er biologisk plausibelt at BPC-157 har effekt ved oral inntak for gastrointestinale indikasjoner (der peptidet virker lokalt i GI-trakten uten mtte absorberes systemisk), og noen dyrestudier sttter dette